Leiner recapitalization complete
This article was originally published in The Tan Sheet
Executive Summary
Sale of North Castle Partners' majority stake in private labeler Leiner Health Products is finalized, the private equity firm announces May 27. A $265 mil. investment in Leiner by private equity firm Golden Gate and North Castle makes the two firms co-sponsors of Leiner and is part of the $650 mil. recapitalization. North Castle talked with several equity firms prior to announcing the deal (1"The Tan Sheet" Feb. 23, 2004, p. 3)...
You may also be interested in...
Leiner Ownership Expected To Change Hands In Recapitalization Deal
North Castle Partners is reportedly in the second round of talks to sell its stake in Leiner Health Products to another private equity firm
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.